Related Experiment Video
Updated: Jul 18, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Health outcomes beyond glucose control
1Translational Metabolism Unit, Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, Texas, USA.
The American Journal of Managed Care
|November 23, 2006
Summary
Diabetes mellitus and cardiovascular disease share insulin resistance as a common link. Early intervention with lifestyle changes and thiazolidinediones (TZDs) can reduce complications and healthcare costs.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Medicine
- Health Economics
Background:
- Diabetes mellitus imposes significant direct and indirect economic burdens on the US healthcare system.
- Cardiovascular disease (CVD) is closely interrelated with diabetes, with a substantial portion of CVD burden attributable to diabetes.
- Insulin resistance is a potential common link between diabetes and CVD, often presenting as metabolic syndrome.
Purpose of the Study:
- To evaluate the role of thiazolidinediones (TZDs) in managing insulin resistance and associated cardiovascular risk factors.
- To assess the impact of early, aggressive interventions on the progression of diabetes and its complications.
- To determine the potential of these interventions in reducing healthcare resource utilization and costs.
Main Methods:
- Review of large clinical trials investigating lifestyle modifications and pharmacotherapy, including TZDs.
- Analysis of data on the effects of TZDs on insulin resistance, lipids, blood pressure, and other cardiovascular risk factors.
- Examination of evidence regarding the reduction of diabetes progression and cardiovascular complications in high-risk populations.
Main Results:
- Thiazolidinediones (TZDs) demonstrate efficacy in reducing insulin resistance.
- TZDs show favorable effects on key cardiovascular risk factors such as lipids and blood pressure.
- Early intervention strategies, including lifestyle changes and pharmacotherapy, have been shown to slow diabetes progression and reduce complications.
Conclusions:
- Early and aggressive management of high-risk patients with lifestyle changes and pharmacotherapy, including TZDs, can mitigate diabetes progression.
- These interventions may significantly reduce the risk of cardiovascular and other diabetes-related complications.
- Effective management strategies have the potential to lower healthcare resource utilization and associated economic burdens.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...